IRIS
AMATI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.485
NA - Nord America 1.326
EU - Europa 531
SA - Sud America 225
AF - Africa 37
OC - Oceania 10
Totale 3.614
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.280
SG - Singapore 861
CN - Cina 312
BR - Brasile 190
IT - Italia 130
VN - Vietnam 123
FI - Finlandia 86
IE - Irlanda 63
DE - Germania 62
GB - Regno Unito 56
IN - India 47
HK - Hong Kong 39
SE - Svezia 33
RU - Federazione Russa 26
CA - Canada 23
BD - Bangladesh 22
FR - Francia 21
AR - Argentina 16
MX - Messico 16
IQ - Iraq 13
TR - Turchia 12
PL - Polonia 11
ES - Italia 10
AU - Australia 8
JP - Giappone 8
PK - Pakistan 8
ZA - Sudafrica 7
NL - Olanda 6
ID - Indonesia 5
KE - Kenya 5
LT - Lituania 5
MA - Marocco 5
PE - Perù 5
UA - Ucraina 5
AO - Angola 4
DZ - Algeria 4
EC - Ecuador 4
MY - Malesia 4
NG - Nigeria 4
PH - Filippine 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
CR - Costa Rica 3
LV - Lettonia 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
EG - Egitto 2
GR - Grecia 2
JO - Giordania 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
TN - Tunisia 2
AT - Austria 1
CI - Costa d'Avorio 1
CL - Cile 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KR - Corea 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MN - Mongolia 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
UY - Uruguay 1
Totale 3.614
Salva come PNG Salva come JPEG
Città #
Singapore 373
Ashburn 248
San Jose 211
Shanghai 154
The Dalles 130
Boardman 108
New York 89
Helsinki 86
Beijing 79
Dallas 68
Dublin 62
Los Angeles 45
Ho Chi Minh City 41
Hong Kong 32
Milan 27
London 24
Naples 22
Falkenstein 21
Hanoi 21
Moscow 19
Pune 17
São Paulo 17
Assago 16
Chennai 16
Chandler 14
Santa Clara 14
Da Nang 11
Orem 11
Seattle 11
Warsaw 11
Council Bluffs 9
Chicago 8
Montreal 8
Shijiazhuang 8
Brooklyn 7
Frankfurt am Main 7
Stockholm 7
Ankara 6
Boston 6
Denver 6
Dhaka 6
Rio de Janeiro 6
San Francisco 6
Baghdad 5
Casal di Principe 5
Johannesburg 5
Manchester 5
Mexico City 5
Phoenix 5
Wanchai 5
Atlanta 4
Benin City 4
Hangzhou 4
Lima 4
Mumbai 4
Nairobi 4
Quận Ba 4
Santo André 4
Southwark 4
Amsterdam 3
Belo Horizonte 3
Cagliari 3
Campinas 3
Dolianova 3
Florence 3
Goiânia 3
Guangzhou 3
Guildford 3
Haiphong 3
Hillsboro 3
Hải Dương 3
Kuala Lumpur 3
Luanda 3
Melbourne 3
Montecassiano 3
Munich 3
Poplar 3
Presidente Prudente 3
St Petersburg 3
Sydney 3
São José do Rio Preto 3
Tashkent 3
Thái Nguyên 3
Toronto 3
Valencia 3
Verona 3
Amman 2
Asagayakita 2
Assendelft 2
Athens 2
Auckland 2
Baku 2
Berlin 2
Bexley 2
Birmingham 2
Blumenau 2
Buffalo 2
Bắc Ninh 2
Calgary 2
Casablanca 2
Totale 2.268
Salva come PNG Salva come JPEG
Nome #
Diagnosis and management of patients with alpha 1-antitrypsin deficiency: an Italian perspective 112
COVID-19 in Immunocompromised Patients: A Systematic Review 105
Community-acquired pneumonia 88
Cardiovascular Complications in Community-Acquired Pneumonia 84
COVID-19 in lung transplant recipients: A case series from Milan, Italy 78
Diagnosis and Initial Investigation of Bronchiectasis 74
COVID-19 Network: the response of an Italian Reference Institute to research challenges about a new pandemia 72
Treatable traits in interstitial lung diseases: a call to action 70
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients 70
An extensive bundle of tests is needed to detect treatable causes of bronchiectasis (Bx) 69
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 66
Cardiovascular side-effects of common antibiotics 66
Post-COVID-19 sequelae 66
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 64
What is the best technique to extract bacterial DNA from sputum? 64
COVID-19 multidisciplinary high dependency unit: the Milan model 63
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes 62
Comparison of different conditions for DNA extraction in sputum - a pilot study 62
Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience 62
Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis 62
Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia 62
Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia 61
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 61
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 60
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review 59
Antibiotics for lung disease and cancer 58
How to Identify Causes and Predisposing Factors in Bronchiectasis 57
Respiratory failure in COVID-19: a patient's perspective and clinical cases 57
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 57
Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience 56
Dysregulation of the microbial ‘gut-lung’ axis in bronchiectasis 55
Overweight and obesity in adults with cystic fibrosis: An Italian multicenter cohort study 54
Neutrophil elastase in bronchiectasis 54
Site of care and multidisciplinary approach 54
Investigating the Etiology of Bronchiectasis: You Do Not Find What You Do Not Look For 54
Thrombocytosis during Stable State Predicts Mortality in Bronchiectasis 52
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 50
Protease-Antiprotease Imbalance in Bronchiectasis 50
First Report of the Prevalence at Baseline and after 1-Year Follow-Up of Treatable Traits in Interstitial Lung Diseases 50
Innate and Adaptive Lymphocytes in Non-Tuberculous Mycobacteria Lung Disease: A Review 49
Immunodeficiencies and CFTR dysfunction: results from a systematic screening in a cohort of adults with cystic fibrosis and CFTR-related disorders 49
Walking the path of treatable traits in interstitial lung diseases 48
Diagnostic delay in bronchiectasis: an Italian perspective 48
T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis 48
SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity 48
Emerging Resistance of Gram Negative Pathogens in Community-Acquired Pneumonia 48
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review 47
The biology of pulmonary exacerbations in bronchiectasis 47
Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy 45
Onset of systemic arterial hypertension after initiation of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: A case series 45
Phenotyping in bronchiectasis: are we moving toward a personalized medicine? 45
Treatable Traits in Systemic Sclerosis 44
Risk factors and guideline adherence of empiric antibiotic use in community-acquired pneumonia 43
One Size Does Not Fit All: Moving Towards a Personalized Approach for Steroids in COVID-19 43
Microbial Inflammatory Networks in Bronchiectasis Exacerbators With Pseudomonas aeruginosa 42
Lung Recruitability of COVID-19 Pneumonia in Patients Undergoing Helmet CPAP 40
Prognostic value of copeptin and mid-regional proadrenomedullin in COVID-19-hospitalized patients 40
Response to: are there over 200 distinct types of interstitial lung diseases? 39
Switching to nebulised short acting bronchodilators does not increase the risk of arrhythmia in patients hospitalized with a COPD exacerbation 39
Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients 39
Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis 37
Predictors of Helmet CPAP Failure in COVID-19 Pneumonia: A Prospective, Multicenter, and Observational Cohort Study 36
Glucocorticoid Therapy in COVID-19 35
Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis 34
Relationship Between Lung Volumes and Heterogeneity in the Response to Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung Disease 32
Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis 32
Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review 31
Totale 3.693
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.902
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.902
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211 0 0 0 0 0 0 0 0 2 3 4 2
2022/2023225 4 3 3 5 6 0 63 8 32 63 27 11
2023/2024715 53 64 122 67 32 107 68 31 9 45 50 67
2024/2025906 15 7 17 24 32 105 55 35 204 209 93 110
2025/20261.836 322 130 74 114 130 116 623 95 133 99 0 0
Totale 3.693